Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer

This study has been terminated.

Study NCT00140075 Information provided by Pfizer

First Received: August 29, 2005 Last Updated: March 17, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	December 2008
Estimated Primary Completion Date:	No date given